References
- Anton N, Vandamme TF. (2009). The universality of low-energy nano-emulsification. Int J Pharm 377:142–7
- Aungst BJ. (1993). Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci 82:979–86
- Bali B, Ali M, Ali J. (2010). Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surfaces B: Biointerfaces 76:410–20
- Bali V, Ali M, Ali J. (2011). Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment. Int J Pharm 403:46–56
- Bandyopadhyay S, Katare OP, Singh B. (2012). Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B Biointerfaces 100:50–61
- Cao G, Sofic E, Prior RL. (1997). Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 22:749–60
- Chaurasiya A, Singh AK, Jain G K, et al. (2012). Dual approach utilizing self microemulsifying technique and novel P-gp inhibitor for effective delivery of taxanes. J Microencapsulation 29:583–95
- Constantinides PP. (1995). Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res 12:1561–72
- Date AA, Nagarsenker MS. (2007). Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm 329:166–72
- El-Laithy HM. (2008). Self-nanoemulsifying drug delivery system for enhanced bioavailability and improved hepatoprotective activity of biphenyl dimethyl dicarboxylate. Curr Drug Deliv 5:170–6
- Ghai D, Sinha VR. (2012). Nanoemulsions as self-emulsified drug delivery carriers for enhanced permeability of the poorly water-soluble selective β1-adrenoreceptor blocker Talinolol. Nanomedicine 8:618–26
- Goldwasser J, Cohen PY, Yang E, et al. (2010). Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARa, PPARc and LXRa. PLoS one 5:12399
- Gupta S, Chavhan S, Sawant KK. (2011). Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surfaces A: Physicochem Eng Aspects 392:145–55
- Hollman PC, Katan MB. (1996). Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol 37:937–42
- Jayaraman J, Veerappan M, Namasivayam N. (2009). Potential beneficial effect of naringenin on lipid peroxidation and antioxidant status in rats with ethanol-induced hepatotoxicity. J Pharm Pharmacol 61:1383–90
- Kanaze FI, Kokkalou E, Niopas I, et al. (2006). Dissolution enhancement of flavonoids by solid dispersions in PVP and PEG matrixes, a comparative study. J Appl Polym Sci 102:460–71
- Khan AW, Kotta S, Ansari SH, et al. (2012). Potentials and challenges in self-nanoemulsifying drug delivery systems. Expert Opin Drug Deliv 9:1305–17
- Kotta S, Khan AW, Pramod K, et al. (2012). Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv 9:585–98
- La Vecchia C, Tavani A. (1998). Fruits and vegetables, and human cancer. Eur J Cancer Prev 7:3–8
- Lawrence MJ, Rees GD. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45:89–121
- Lee CH, Jeong TS, Choi YK, et al. (2001). Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun 84:681–8
- Lee MH, Yoon S, Moon JO. (2004). The flavonoid naringenin inhibits dimethylnitrosamine induced liver damage in rats. Biol Pharm Bull 27:72–6
- Liu RH. (2004). Synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 134:3479S–85S
- Ma Y, Li P, Chen D, et al. (2006). LC/MS/MS quantitation assay for pharmacokinetics of naringenin and double peaks phenomenon in rats plasma. Int J Pharm 307:292–9
- Madsen HL, Andersen CM, Jorgensen LV, Skibsted LH. (2000). Radical scavenging by dietary flavonoids. A kinetic study of antioxidant efficiencies. Eur Food Res Tech 211:240–6
- Manthey JA. (2000). Biological properties of flavonoids pertaining to inflammation. Microcirculation. 7:S29–34
- Middleton E Jr, Kandaswami C, Theoharides TC. (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673–751
- Miyake K, Arima H, Hirayama F, et al. (2000). Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin. Pharm Dev Technol 5:399–407
- Nazzal S, Smalyukh II, Lavrentovich OD, Khan MA. (2002). Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int J Pharm 235:247–65
- Nepal PR, Han HK, Choi HK. (2010). Preparation and in vitro-in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q(10). Eur J Pharm Sci 39:224–32
- O’Reilly JD, Sanders TA, Wiseman H. (2000). Flavonoids protect against oxidative damage to LDL in vitro: use in selection of a flavonoid rich diet and relevance to LDL oxidation resistance ex vivo? Free Radic Res 33:419–26
- Raj KJ, Shalini K. (1999). Flavonoids-a review of biological activities. Ind Drugs 36:668–76
- Rang MJ, Miller CA. (1999). Spontaneous emulsification of oils containing hydrocarbon, nonionic surfactant, and oleyl alcohol. J Colloid Interface Sci 209:179–92
- Rice-Evans CA, Miller NJ, Paganga G. (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933–56
- Scalbert A, Williamson G. (2000). Dietary intake and bioavailability of polyphenols. J Nutr 130:2073S–85S
- Semalty A, Semalty M, Singh D, Rawat MSM. (2010). Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. J Incl Phenom Macrocycl Chem 67:253–60
- Shen H, Zhong M. (2006). Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J Pharm Pharmacol 58:1183–91
- Singh B, Bandopadhyay S, Kapil R, Singh R, et al. (2009). Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst 26:427–521
- Sinha S, Ali M, Baboota S, Ahuja A, et al. (2010). Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS Pharm Sci Tech 11:518–27
- Tommasini S, Calabrò ML, Raneri D, et al. (2004). Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin. J Pharm Biomed Anal 36:327–33
- Wang L, Dong J, Chen J, et al. (2009). Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci 330:443–8
- Yu J, Wang L, Walzem RL, et al. (2005). Antioxidant activity of citrus limonoids, flavonoids, and coumarins. J Agric Food Chem 53:2009–14
- Zhang H, Yao M, Morrison RA, Chong S. (2003). Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats. Arch Pharm Res 26:768–72
- Zhao G, Duan J, Xie Y, et al. (2013). Effects of solid dispersion and self-emulsifying formulations on the solubility, dissolution, permeability and pharmacokinetics of isorhamnetin, quercetin and kaempferol in total flavones of Hippophae rhamnoides L. Drug Dev Ind Pharm 39:1037–45
- Zhao Y, Wang C, Chow AH, et al. (2010). Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation andbioavailability studies. Int J Pharm 383:170–7